You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京醫藥(600713.SH):安徽天星擬以增資擴股方式併購嘉勉生物51%股權
格隆匯 03-30 20:22

格隆匯3月30日丨南京醫藥(600713.SH)公佈,公司控股子公司安徽天星醫藥集團有限公司(以下簡稱“安徽天星”)擬以增資擴股方式併購安徽嘉勉生物製品有限公司(以下簡稱“嘉勉生物”或“目標公司”)51%股權。

嘉勉生物100%股權資產評估價值為1960萬元(人民幣,下同),最終評估結果以經國資監管部門備案後為準。安徽天星擬按照上述資產評估價值為作價依據,對嘉勉生物以現金方式增資2040萬元,併購其51%股權。本次增資完成後,嘉勉生物註冊資本由1960萬元增加至4000萬元,其中安徽天星出資2040萬元,持有嘉勉生物51%股權。

安徽天星通過增資擴股併購嘉勉生物51%股權,與合作方共同整合優勢資源,努力開發新市場,引進新品種,做深做透安徽省內血液製品市場,拓展疫苗配送市場,將嘉勉生物打造成為安徽天星在安徽省內專業血液製品銷售和疫苗配送業務承接平台,3-5年內成為區域專業市場龍頭企業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account